Reversible Left Ventricular Systolic Dysfunction-Reversibility of Coronary Microvascular Abnormality.
نویسندگان
چکیده
منابع مشابه
Reversible segmental left ventricular dysfunction after coronary angioplasty.
Patients with chronic segmental myocardial dysfunction may demonstrate improvement after coronary revascularization. To evaluate the early effects of percutaneous transluminal coronary angioplasty (PTCA) on resting left ventricular segmental function, we obtained serial two-dimensional echocardiograms 1.1 +/- 0.9 days before and 3.1 +/- 2 days after elective PTCA in 40 patients. Echocardiograms...
متن کاملRethinking Revascularization in Left Ventricular Systolic Dysfunction.
Survival Benefits of Invasive Versus Conservative Strategies in Heart Failure in Patients With Reduced Ejection Fraction and Coronary Artery Disease: A Meta-Analysis Georg Wolff, MD; Dimitrios Dimitroulis, MD; Felicita Andreotti, MD, PhD, FESC; Michalina Kołodziejczak, MD; Christian Jung, MD, PhD; Pietro Scicchitano, MD; Fiorella Devito, MD; Annapaola Zito, MD; Michele Occhipinti, MD; Battistin...
متن کاملLeft ventricular systolic dysfunction in rheumatoid disease.
OBJECTIVES This study sought to ascertain whether left ventricular systolic dysfunction (LVSD) is more common among clinic patients with rheumatoid disease (RD) compared with the general population, and to assess the diagnostic utility of brain natriuretic peptide (BNP). BACKGROUND Patients with RD are at increased risk of ischemic heart disease. However, there are few large echocardiographic s...
متن کاملReversible left ventricular dysfunction in suicidal hanging.
Acute and rapidly reversible left ventricular dysfunction may be triggered by various psychological and physical insults. This entity is now well known as stress cardiomyopathy or Takotsubu cardiomyopathy. Suicidal hanging involves intense emotional outburst and the act of hanging is an extreme physical stress. We report a case of rapidly reversible left ventricular dysfunction following attemp...
متن کاملBortezomib induced reversible left ventricular systolic dysfunction: A case report and review of literature
Bortezomib is a reversible proteasome inhibitor, currently approved by US FDA for use in multiple myeloma and mantle cell lymphoma. Bortezomib has been shown to cause new onset and exacerbation of underlying congestive cardiac failure (CHF) in some case reports. Studies on human tissue have shown dysregulation of ubiquitin proteasome system (UPS) in cardiac tissues in end stage heart failure. R...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Japanese Heart Journal
سال: 2001
ISSN: 0021-4868,1348-673X
DOI: 10.1536/jhj.42.355